TCF3::PBX1 (E2A::PBX1) t(1;19)
Quantitative RT-PCR detection of TCF3::PBX1 (E2A::PBX1) fusion from t(1;19) for ALL diagnosis and minimal residual disease monitoring.
KMT2A::MLLT3 (MLL::AF9) t(9;11)
Quantitative RT-PCR detection of KMT2A::MLLT3 fusion transcripts from the t(9;11) translocation.
WT1 Gene Transcript Levels by RT-PCR
Quantitative RT-PCR determination of Wilms' Tumor (WT1) transcript levels for MDS and AML monitoring.
PML::RARA t(15;17)
Multiplex RT-PCR detection of PML::RARA fusion transcripts (long, variant, short isoforms) for acute promyelocytic leukemia diagnosis and monitoring. STAT testing available.
KMT2A::AFDN t(6;11) (aka KMT2A::MLLT4 or MLL::AF6)
Quantitative RT-PCR detection of KMT2A::AFDN fusion transcripts from t(6;11) involving the 11q23 KMT2A locus.
BCR::ABL1 IS t(9;22)
Quantitative RT-PCR detection and monitoring of the t(9;22) BCR::ABL1 fusion transcript (p210 and p190) for CML, ALL, and AML diagnosis and MRD.
KMT2A::MLLT11 (MLL::AF1) t(1;11)
Quantitative RT-PCR detection of KMT2A::MLLT11 fusion transcripts from the t(1;11) translocation.
CBFB::MYH11 inv(16) or t(16;16)
Quantitative RT-PCR detection and monitoring of CBFB::MYH11 fusion transcripts (types A, D, E) from inv(16)/t(16;16) in AML.
CBFA2T3::GLIS2
Quantitative RT-PCR detection and monitoring of the inv(16)(p13.3q24.3) CBFA2T3::GLIS2 fusion in AML with RAM immunophenotype.
KAT6A::CREBBP t(8;16)
Quantitative RT-PCR detection of the KAT6A::CREBBP fusion from t(8;16)(p11;p13) translocation in a subset of AML patients.
